ICH Q10: Pharmaceutical Quality System

Context and history

ICH Q10 describes a model for an effective pharmaceutical quality system across the product lifecycle. FDA published it as guidance on 8 April 2009, and EU GMP includes it in Part III. EU Chapter 1 was aligned with it in 2013.

Q10 says it is not intended to create new expectations beyond current regulatory requirements, and that content going beyond regional GMP is optional. It joins two enablers, knowledge management and quality risk management, to four elements of the system: process performance monitoring, CAPA, change management and management review.

Who and what it applies to

Systems supporting the development and manufacture of drug substances and drug products, including biotechnology and biological products, throughout the lifecycle. FDA says the elements should be applied in a way that is appropriate and proportionate to each stage.

What it contains

1 Pharmaceutical quality system

Scope, its relationship to GMP, objectives (product realisation, a state of control, continual improvement), and enablers.

2 Management responsibility

Commitment, quality policy, planning, resources, internal communication, management review, management of outsourced activities and purchased materials, and change in product ownership.

3 Continual improvement of process performance and product quality

Lifecycle stage goals: development, technology transfer, commercial manufacturing, product discontinuation. System elements: process performance and product quality monitoring, CAPA, change management, management review.

4 Continual improvement of the quality system

Management review of the system, internal and external factors, and outcomes.

Annexes

Includes the potential for regulatory approaches based on enhanced knowledge, and a diagram of the model.

Key points

• Senior management is responsible for the system.
• It builds on GMP, spans the lifecycle, and says it creates no new regulatory expectations.
• Knowledge management and risk management are enablers.
• Outsourced activities and purchased materials stay within the firm's responsibility.
• Monitoring, CAPA, change management and management review are the four core elements.

In practice

General reading, not advice. This is drafted with AI and may not fit your situation. It does not replace the official text, your own quality system or qualified advice, and an inspector may take a different view.

• Use it to explain why computerised systems sit inside the quality system, not beside it.
• Include computerised system performance and data integrity in management review.
• Treat vendor and cloud services as outsourced activities in need of oversight.

Read from the source document on 1 Nov 2026. This is our own description, not the official text. Check the full dated history in the change log below.